316 related articles for article (PubMed ID: 1378833)
21. Analysis of ligand binding to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that lipoprotein lipase and the carboxyl-terminal domain of the receptor-associated protein bind to the same site.
Nielsen MS; Nykjaer A; Warshawsky I; Schwartz AL; Gliemann J
J Biol Chem; 1995 Oct; 270(40):23713-9. PubMed ID: 7559542
[TBL] [Abstract][Full Text] [Related]
22. Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes.
Teesalu T; Blasi F; Talarico D
Mech Dev; 1996 May; 56(1-2):103-16. PubMed ID: 8798151
[TBL] [Abstract][Full Text] [Related]
23. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
Conese M; Blasi F
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
[TBL] [Abstract][Full Text] [Related]
24. Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.
Andreasen PA; Sottrup-Jensen L; Kjøller L; Nykjaer A; Moestrup SK; Petersen CM; Gliemann J
FEBS Lett; 1994 Feb; 338(3):239-45. PubMed ID: 8307187
[TBL] [Abstract][Full Text] [Related]
25. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
[TBL] [Abstract][Full Text] [Related]
26. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells.
Zhang JC; Sakthivel R; Kniss D; Graham CH; Strickland DK; McCrae KR
J Biol Chem; 1998 Nov; 273(48):32273-80. PubMed ID: 9822706
[TBL] [Abstract][Full Text] [Related]
27. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes.
Nykjaer A; Conese M; Christensen EI; Olson D; Cremona O; Gliemann J; Blasi F
EMBO J; 1997 May; 16(10):2610-20. PubMed ID: 9184208
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
29. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility.
Chazaud B; Bonavaud S; Plonquet A; Pouchelet M; Gherardi RK; Barlovatz-Meimon G
Exp Cell Res; 2000 Aug; 258(2):237-44. PubMed ID: 10896774
[TBL] [Abstract][Full Text] [Related]
31. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.
Cubellis MV; Wun TC; Blasi F
EMBO J; 1990 Apr; 9(4):1079-85. PubMed ID: 2157592
[TBL] [Abstract][Full Text] [Related]
32. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
[TBL] [Abstract][Full Text] [Related]
33. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase.
Nykjaer A; Bengtsson-Olivecrona G; Lookene A; Moestrup SK; Petersen CM; Weber W; Beisiegel U; Gliemann J
J Biol Chem; 1993 Jul; 268(20):15048-55. PubMed ID: 7686910
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific expression of the relaxed conformation of plasminogen activator inhibitor-2 and low-density lipoprotein receptor-related protein in human term gestational tissues.
Tsatas D; Baker MS; Rice GE
J Histochem Cytochem; 1997 Dec; 45(12):1593-602. PubMed ID: 9389762
[TBL] [Abstract][Full Text] [Related]
35. Both pro-uPA and uPA: PAI-1 complex bind to the alpha 2-macroglobulin receptor/LDL receptor-related protein. Evidence for multiple independent contacts between the ligands and receptor.
Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Gliemann J; Andreasen PA
Ann N Y Acad Sci; 1994 Sep; 737():483-5. PubMed ID: 7944152
[No Abstract] [Full Text] [Related]
36. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor.
Degryse B; Sier CF; Resnati M; Conese M; Blasi F
FEBS Lett; 2001 Sep; 505(2):249-54. PubMed ID: 11566185
[TBL] [Abstract][Full Text] [Related]
37. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G
J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
[TBL] [Abstract][Full Text] [Related]
38. The urokinase/PAI-2 complex: a new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein.
Croucher D; Saunders DN; Ranson M
J Biol Chem; 2006 Apr; 281(15):10206-13. PubMed ID: 16459332
[TBL] [Abstract][Full Text] [Related]
39. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
Estreicher A; Mühlhauser J; Carpentier JL; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):783-92. PubMed ID: 2166055
[TBL] [Abstract][Full Text] [Related]
40. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
